Nathalie Vaissière

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

Karin Hardt, An Vandebosch, Jerald Sadoff et al. · The Lancet Infectious Diseases · 2022 · 88 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

GILT—A randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best supportive care alone in stage III non-small cell lung cancer

Michael Flentje, Rudolf M. Huber, Walburga Engel-Riedel et al. · Strahlentherapie und Onkologie · 2016 · 76 citations

Medicine, Oncology, Radiation Oncology +15

Phase III Trial Comparing Vinflunine With Docetaxel in Second-Line Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy

Maciej Krzakowski, Rodryg Ramlau, Jacek Jassem et al. · Journal of Clinical Oncology · 2010 · 75 citations

Medicine, Oncology, Pharmacology +13

Vinflunine–gemcitabine versus vinflunine–carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)

Maria De Santis, Paweł Wiechno, Joaquim Bellmunt et al. · Annals of Oncology · 2015 · 55 citations · Full text

Medicine, Oncology, Pharmacology +16

All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial

N. Tubiana-Mathieu, Philippe Bougnoux, D. Becquart et al. · British Journal of Cancer · 2009 · 46 citations · Full text

Medicine, Oncology, Pharmacology +17